Improving Clinical Trial Interpretation with ACCEPT Analyses-Reference-Cited by-同舟云学术

Improving Clinical Trial Interpretation with ACCEPT Analyses

Published:2022-07-26 Issue:8 Volume:1 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Clements Michelle N.¹,White Ian R.¹,Copas Andrew J.¹,Cornelius Victoria²,Cro Suzie²,Dunn David T.¹,Quartagno Matteo¹,Turner Rebecca M.¹,Tweed Conor D.¹,Walker A. Sarah¹

Affiliation:

1. MRC Clinical Trials Unit at UCL, London

2. Imperial Clinical Trials Unit, Imperial College London, London

Publisher

Massachusetts Medical Society

Reference14 articles.

1. Scientists rise up against statistical significance

2. New Guidelines for Statistical Reporting in the Journal

3. Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa

4. Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study

5. Superiority and non-inferiority: two sides of the same coin?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial;eClinicalMedicine;2024-03

2. Inhaled Nitric Oxide ReDuce postoperatIve pulmoNAry complicaTions in patiEnts with recent COVID-19 infection (INORDINATE): protocol for a randomised controlled trial;BMJ Open;2024-03

3. Non-randomised feasibility study of training workshops for Talking Therapies service high-intensity therapists to optimise depression and anxiety outcomes for individuals with co-morbid personality difficulties: a study protocol;Pilot and Feasibility Studies;2023-10-05

4. Practical approaches to Bayesian sample size determination in non‐inferiority trials with binary outcomes;Statistics in Medicine;2023-01-20

5. Interface — A New Series from NEJM Evidence;NEJM Evidence;2022-07-26